Multidrug-resistant Tuberculosis (MDR TB)
Aswita Damayanti(1*), Alfi Raudatil Jannah(2)
(1) Puskesmas Kaligesing Purworejo; Purworejo; Jawa Tengah; Indonesia
(2) Department of Family and Community Medicine; Faculty of Medicine, Public Health and Nursing; Universitas Gadjah Mada; Indonesia
(*) Corresponding Author
Abstract
Keywords
Full Text:
PDFReferences
1. Sun Y, Harley D, Vally H, Sleigh A. Comparison of characteristics and mortality in multidrug-resistant (MDR) and non-MDR tuberculosis patients in China. BMC Public Health. 2015;15(1).
2. Ministry of Health, Republic of Indonesia. Technical guidelines for integrated management of control of tuberculosis drug resistance. Jakarta: Ministry of Health, Republic of Indonesia. 2013
3. Seung K, Keshavjee S, Rich M. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harbor Perspectives in Medicine. 2015;5(9):a017863.
4. Marahatta S. Multi-drug resistant tuberculosis burden and risk factors: An update. Kathmandu University Medical Journal. 2010;8(12):116-125.
5. Sharma S, Mohan A. Multidrug-Resistant Tuberculosis. Indian Journal of Medical Research. 2004;120:354-376.
6. Rich M, Jaramillo E. Companion Handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization. 2014.
7. Jaramillo E, Blanc L. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization. 2011.
8. Surya A, Basri C, Kamso S. National tuberculosis control guidelines. Jakarta: Ministry of Health, Republic of Indonesia. 2011.
9. Husain F. Guidelines for prevention and control of tuberculosis infection in hospitals. Jakarta: Department of Health of the Republic of Indonesia. 2010.
10. Sairenji T, Wilson SA, D'Amico F, Peterson LE. Training family medicine residents to perform home visits: a CERA survey. Journal of Graduate Medical Education. 2017 Feb;9(1):90-6.
11. Brian K. Unwin, Anthony F. Jerant. The home visit. American Family Physician. 1999;60(5):1481-1488.
12. Törün T, Güngör G, Ozmen I, Bölükbaşi Y, Maden E, Biçakçi B, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease. 2005;9(12).
13. Tag El Din M, El Maraghy A, Abdel Hay A. Adverse reactions among patients being treated for multi-drug resistant tuberculosis at Abbassia Chest Hospital. Egyptian Journal of Chest Diseases and Tuberculosis. 2015;64(4):939-952.
14. Chung-Delgado K, Guillen-Bravo S, Revilla-Montag A, Bernabe-Ortiz A. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors. PloS One. 2015 Mar 19;10(3):e0119332.
DOI: https://doi.org/10.22146/rpcpe.41700
Article Metrics
Abstract views : 2243 | views : 4869Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Aswita Damayanti, Alfi Raudatil Jannah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.